Hazard ratio (HR) values for association between treatment (any disease-modifying antirheumatic drugs, biological agents and/or glucocorticoids) and individual cardiovascular diseases (CVDs) in 345 patients with sarcoidosis during 1976–2013
| HR (95% CI)# | p-value | |
| Coronary artery disease | 1.25 (0.72–2.18) | 0.43 |
| Congestive heart failure | 1.58 (0.86–2.90) | 0.14 |
| Atrial fibrillation | 0.76 (0.37–1.56) | 0.46 |
| Cerebrovascular accident | 0.92 (0.45–1.89) | 0.83 |
| Transient ischaemic attack | 0.27 (0.03–2.38) | 0.24 |
| Peripheral arterial disease | 2.22 (0.71–6.93) | 0.17 |
| Abdominal aortic aneurysm | 0.51 (0.05–5.49) | 0.58 |
| Any CVD | 1.25 (0.83–1.90) | 0.29 |
#: adjusted for age, sex and calendar year of sarcoidosis incidence/index date.